BR112018008833A2 - nutritional compositions comprising lactobacillus rhamnosus gg, as well as dietary butyrate and / or a compound for stimulating endogenous butyrate formation - Google Patents

nutritional compositions comprising lactobacillus rhamnosus gg, as well as dietary butyrate and / or a compound for stimulating endogenous butyrate formation

Info

Publication number
BR112018008833A2
BR112018008833A2 BR112018008833A BR112018008833A BR112018008833A2 BR 112018008833 A2 BR112018008833 A2 BR 112018008833A2 BR 112018008833 A BR112018008833 A BR 112018008833A BR 112018008833 A BR112018008833 A BR 112018008833A BR 112018008833 A2 BR112018008833 A2 BR 112018008833A2
Authority
BR
Brazil
Prior art keywords
butyrate
nutritional compositions
lactobacillus rhamnosus
compound
well
Prior art date
Application number
BR112018008833A
Other languages
Portuguese (pt)
Other versions
BR112018008833A8 (en
Inventor
A F Van Tol Eric
M Gonzalez Juan
Tim Lambers Teartse
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/936,014 external-priority patent/US20170127693A1/en
Priority claimed from US14/959,107 external-priority patent/US10034937B2/en
Priority claimed from US15/011,797 external-priority patent/US20170215464A1/en
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of BR112018008833A2 publication Critical patent/BR112018008833A2/en
Publication of BR112018008833A8 publication Critical patent/BR112018008833A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

a presente invenção refere-se a composições nutricionais compreendendo uma combinação do probiótico lactobacillus rhamnosus gg, butirato de dieta e/ou um componente para estimulação de produção de butirato endógeno, por exemplo, a combinação de polidextrose e galacto-oligossacarídeos, no intestino humano. são ainda mostrados processos de aceleração de tolerância a leite de vaca em um sujeito pediátrico através de provimento de ditas composições nutricionais para um sujeito alvo.The present invention relates to nutritional compositions comprising a combination of the probiotic lactobacillus rhamnosus gg, dietary butyrate and / or a component for stimulating endogenous butyrate production, for example, the combination of polydextrose and galactooligosaccharides, in the human intestine. Further processes for accelerating cow's milk tolerance in a pediatric subject by providing said nutritional compositions for a target subject are further shown.

BR112018008833A 2015-11-09 2016-10-19 nutritional compositions comprising lactobacillus rhamnosus gg, as well as dietary butyrate and / or a compound for stimulating endogenous butyrate formation BR112018008833A8 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14/936,014 US20170127693A1 (en) 2015-11-09 2015-11-09 Nutritional compositions containing butyrate and uses thereof
US14/959,107 US10034937B2 (en) 2015-12-04 2015-12-04 Synergistic nutritional compositions and uses thereof
US15/011,797 US20170215464A1 (en) 2016-02-01 2016-02-01 Nutritional compositions containing dietary butyrate and uses thereof
PCT/US2016/057644 WO2017083068A1 (en) 2015-11-09 2016-10-19 Nutritional compositions comprising lactobacillus rhamnosus gg, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate

Publications (2)

Publication Number Publication Date
BR112018008833A2 true BR112018008833A2 (en) 2018-11-06
BR112018008833A8 BR112018008833A8 (en) 2019-02-26

Family

ID=57227128

Family Applications (3)

Application Number Title Priority Date Filing Date
BR112018008833A BR112018008833A8 (en) 2015-11-09 2016-10-19 nutritional compositions comprising lactobacillus rhamnosus gg, as well as dietary butyrate and / or a compound for stimulating endogenous butyrate formation
BR112018008040A BR112018008040A2 (en) 2015-11-09 2016-10-19 nutritional composition comprising a casein hydrolyzate as well as a dietary butyrate and / or a compound for stimulating the formation of endogenous butyrate
BR112018008726A BR112018008726A2 (en) 2015-11-09 2016-10-19 butyrate-containing nutritional compositions and uses thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
BR112018008040A BR112018008040A2 (en) 2015-11-09 2016-10-19 nutritional composition comprising a casein hydrolyzate as well as a dietary butyrate and / or a compound for stimulating the formation of endogenous butyrate
BR112018008726A BR112018008726A2 (en) 2015-11-09 2016-10-19 butyrate-containing nutritional compositions and uses thereof

Country Status (12)

Country Link
EP (3) EP3373748A1 (en)
JP (3) JP2018537441A (en)
CN (3) CN108347986A (en)
AU (4) AU2016351454A1 (en)
BR (3) BR112018008833A8 (en)
CA (3) CA3004722A1 (en)
HK (1) HK1256282A1 (en)
MX (3) MX2018005663A (en)
PH (3) PH12018500993A1 (en)
SG (3) SG11201803121WA (en)
TW (3) TW201729692A (en)
WO (3) WO2017083069A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140308212A1 (en) 2011-11-07 2014-10-16 University Of Louisville Research Foundation, Inc. Edible plant-derived microvesicle compositions for diagnosis and treatment of disease
US20210085744A1 (en) * 2017-11-22 2021-03-25 University Of Louisville Research Foundation, Inc. Edible plant-derived nanoparticles for regulation of gut microbiota
IT201800003557A1 (en) * 2018-03-14 2019-09-14 Kolfarma S R L Pharmaceutical preparation or food supplement based on alpha-lactalbumin
BR112021009180A2 (en) * 2018-12-21 2021-08-17 Société des Produits Nestlé S.A. Dietary Butyrate for the Treatment or Prevention of an Allergic Disorder
WO2021110963A1 (en) * 2019-12-05 2021-06-10 Société des Produits Nestlé S.A. Dietary butyrate
CN116585284B (en) * 2023-06-13 2024-03-19 常州市武进人民医院(常州市第八人民医院) Calcitriol soft capsule, preparation method and application thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
AU2004318688A1 (en) * 2004-03-23 2005-11-03 Lytone Enterprise, Inc. Chitosan embedded or encapsulated capsule
CN104705651B (en) * 2005-04-27 2018-05-29 努特里希亚公司 Nutriment containing lipid and stodgy sugar
JP2007131550A (en) * 2005-11-08 2007-05-31 Snow Brand Milk Prod Co Ltd Immunity function regulator
ITRM20080214A1 (en) * 2008-04-21 2009-10-22 Uni Degli Studi Di Napoli Federico Ii DERIVATIVES OF BUTIRRIC ACID ADMINISTRATIVE BY ORAL, FORMULATIONS THAT CONTAIN THEM AND THEIR CLINICAL USE.
IT1392214B1 (en) * 2008-11-28 2012-02-22 Sila S R L PROCESS FOR THE PRODUCTION OF A COMPOUND OF N-BUTIRRIC ACID IN MICROCAPSULATED FORM, INTENDED FOR ANIMAL OR HUMAN POWER
IT1395328B1 (en) * 2009-08-26 2012-09-14 Alpiflor S R L COMPOSITION OF BUTIRRIC ACID MIXED WITH PROBIOTICS AND PREBIOTICS
CN103238730B (en) * 2012-03-22 2014-09-03 杭州康德权饲料有限公司 Preparation method of microencapsulation diolame sodium butyrate
WO2013191533A1 (en) * 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat
US9352020B2 (en) * 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US8889633B2 (en) * 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US10709770B2 (en) * 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US20150119322A1 (en) * 2013-07-31 2015-04-30 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US20150271554A1 (en) * 2014-03-18 2015-09-24 Telefonaktiebolaget L M Ericsson (Publ) Unified rating system and method for selectively blocking content
US20150305384A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics

Also Published As

Publication number Publication date
PH12018500993A1 (en) 2018-11-12
HK1256282A1 (en) 2019-09-20
AU2016351455B2 (en) 2020-08-20
MX2018005663A (en) 2018-08-01
PH12018500992A1 (en) 2018-11-12
WO2017083068A1 (en) 2017-05-18
AU2020257046A1 (en) 2020-11-12
JP2018537084A (en) 2018-12-20
CA3004722A1 (en) 2017-05-18
JP2018532417A (en) 2018-11-08
MX2018005651A (en) 2018-08-01
WO2017083067A1 (en) 2017-05-18
CA3004737A1 (en) 2017-05-18
EP3373749A1 (en) 2018-09-19
EP3373747A1 (en) 2018-09-19
CN108347986A (en) 2018-07-31
EP3373748A1 (en) 2018-09-19
WO2017083069A1 (en) 2017-05-18
MX2018005659A (en) 2018-08-01
BR112018008726A2 (en) 2018-10-30
PH12018500994A1 (en) 2019-01-28
AU2016351455A1 (en) 2018-05-10
AU2016351456A1 (en) 2018-05-10
JP2018537441A (en) 2018-12-20
BR112018008833A8 (en) 2019-02-26
CN108347984A (en) 2018-07-31
SG11201803125XA (en) 2018-05-30
BR112018008040A2 (en) 2018-11-13
TW201729691A (en) 2017-09-01
SG11201803121WA (en) 2018-05-30
AU2020257046B2 (en) 2022-08-11
TW201729693A (en) 2017-09-01
CA3004740A1 (en) 2017-05-18
TW201729692A (en) 2017-09-01
SG11201803123PA (en) 2018-05-30
AU2016351454A1 (en) 2018-05-10
AU2016351456B2 (en) 2020-09-17
CN108347985A (en) 2018-07-31

Similar Documents

Publication Publication Date Title
BR112018008833A2 (en) nutritional compositions comprising lactobacillus rhamnosus gg, as well as dietary butyrate and / or a compound for stimulating endogenous butyrate formation
BR112016024850A2 (en) compositions and methods for modulating antiopoietin-like expression 3
PH12016501953A1 (en) Pediatric nutritional composition with human milk oligosaccharides, prebiotics and probiotics
EA201791702A1 (en) THERAPEUTIC TOOLS ON THE BASIS OF GLYCANS AND RELATED METHODS
MX2022012374A (en) Multi-supplement compositions.
AR106644A1 (en) NUTRITIONAL SYNERGISTIC COMPOSITIONS AND USES OF THE SAME
EA201391823A1 (en) SPRAY-DRIED STRAINS / LACTOBACTERIA CELLS AND THEIR APPLICATION AGAINST HELICOBACTER PYLORI
MX2022011742A (en) Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile.
BR112014016251A8 (en) compositions and methods for modification of gastrointestinal flora
BR112016027871A2 (en) composition to improve memory, learning function and / or cognitive function
BR112018009192A8 (en) prebiotic and probiotic composition combined
BR112017014649A2 (en) "human intestinal isolate and composition"
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
PH12016501952A1 (en) Nutritional compositions directed to subjects having cow`s milk protein allergies
AR097151A1 (en) FOOD FOR INFANT RUMENTS
MX2019002924A (en) Purified human milk oligosaccharides compositions.
MX2018002546A (en) Compositions comprising an urolithin compound.
MX2016012784A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions.
BR112017026834A2 (en) [Use of the inventive name established by ISA under Rule 37.2] The use of a complex vitamin composition for the preparation of a medicament for promoting gastrointestinal motility
BR112018074299A2 (en) pharmaceutical compositions comprising eteplirsen
PH12018550097A1 (en) Infant formula comprising human milk peptides
BR112012020064A2 (en) milk product and method of producing said milk product
GB2550750A (en) Anthelmintic compounds
RU2014138694A (en) Composition for stimulating metabolic processes, the immune system, preventing diarrhea diseases
GB201710316D0 (en) Dietary composition of nicotinamide riboside, choline and succinic acid or salts thereof

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.